neurologic disorders
Guillain Barré Syndrome (GBS)
Prognosis for GBS
Guillain-Barré syndrome is fatal in < 2%. Most patients improve considerably over a period of months, but about 30% of adults and even more children have some residual weakness at 3 years. Patients with residual defects may require retraining, orthopedic appliances, or surgery. After initial improvement, 2 to 5% of patients develop Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (CIDP). 